Direct evidence that a class II molecule and a simple globular protein generate multiple determinants by unknown
DIRECT  EVIDENCE  THAT  A  CLASS  II  MOLECULE  AND 
SIMPLE  GLOBULAR  PROTEIN  GENERATE  MULTIPLE 
DETERMINANTS 
A 
BY  PAUL  M.  ALLEN,*  DAVID J.  McKEAN,*  BARBARA  N.  BECK,* 
JOHN  SHEFFIELD,  §  AND  LAURIE  H.  GLIMCHER § 
From the *Department of Pathology, Washington University School of Medicine, St. Louis, 
Missouri; *Mayo Clinic Medical School, Rochester, Minnesota; and the §Department of Cancer 
Biology, Harvard School of Public Health, Boston, Massachusetts 
It is widely accepted that helper T  cells (Th) ~ recognize antigen in the context 
of la molecules on the surface of antigen-presenting cells (APC) (1, 2). Functional 
and  structural  studies  strongly  suggest that,  like  B  cells,  T  cells have a  single 
antigen  receptor (TcR) (3-5).  Unlike immunoglobulins,  however, TcR appear 
to recognize a bimolecular complex composed of a class II molecule and foreign 
antigen (6, 7). Thus the ligand of the TcR is far more complex than that of the 
B cell. 
Little is currently known about the interaction of the TcR with its bimotecular 
ligand. On the one hand,  this three part interaction  might limit the diversity of 
T  cell antigenic responses if Ia antigens can associate with only a limited number 
of foreign  antigenic  determinants  and  if the  TcR can  recognize  only a  small 
number of Ia epitopes.  On the other hand,  the diversity of the T  cell response 
would be greatly  enlarged  if many foreign antigenic  determinants  can  be pre- 
sented  by  la  molecules and  if numerous  epitopes  on  these  molecules  can  be 
recognized by the TcR. 
We have previously reported studies involving the Ia component of the TcR 
ligand  (8,  9).  These  class  II  Ia  molecules are  composed of two noncovalently 
linked chains, ~ and/3.  It now appears that there are a  limited number of class 
II genes, with six to eight identified in the murine system (10,  11) and  10-12 in 
the human  system (12).  Furthermore,  it has been shown that there is a prefer- 
ential pairing of homozygous Ia~ and Ia~ chains and that not all  possible hybrid 
combinations  are  formed  (13,  14).  Thus,  there  does  not  seem  to  be a  large 
number of class II-encoded gene products.  However, our recent studies exam- 
ining the specificity of alloreactive or autoreactive T  cells (8,  15,  16) and other 
studies examining the I-A mutant B6.C-H-2  bml2 (17, 18), have provided evidence 
that multiple functional epitopes exist on a single Ia molecule. 
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The study presented here is a systematic analysis of the ligand of the TcR. We 
have examined the individual  contributions of the  I-A k chain,  I-A~ chain,  and 
different determinants  on  the  hen  egg-white  iysozyme (HEL) molecule in  the 
formation of the complex being recognized by the  TcR.  As  functional probes 
we have  used (a) a  panel of 10  I-Ak-restricted,  HEL-specific T  cell hybridoma 
clones,  (b) a  panel  of antigen-presenting  B  cell hybridomas that  bear mutated 
I-A~ or I-A~ chains, and (c) proteolytic fragments of HEL and related synthetic 
peptides. Our results provide evidence that a single class II molecule and a simple 
globular protein can generate multiple antigenic determinants.  Thus the associ- 
ation of Ia molecules and foreign antigens can generate extraordinary diversity 
available for the Th cell immune response. 
Materials and  Methods 
T Cell Hybridomas.  T  cell hybridomas specific for HEL were generated by following 
the  established  protocol  of polyethylene glycol  fusion  of primed  T  cells  with  AKR 
thymoma BW5147 cells (3,  18). The resulting T  cell hybridomas secreted interleukin 2 
(IL-2) upon interaction with an Ia-bearing antigen-presenting cell in the presence of HEL. 
The T  cell hybridomas 2A11,  3A9,  19.47, and  18N.30 were generated in two fusions 
from  CBA/J  mice;  T  hybrids  A2.2B2,  C10,  C4.A1,  A4.A1,  A6.A2,  and  B14  were 
generated in two fusions from B10.A mice. All of the T  hybrid lines were subcloned twice 
to insure the donality of each line. 
Antigen-presenting  Cells (APC).  The procedure for the production and characterization 
of the I-A  k mutant APC lines has been previously described in detail (8, 9, 15, 19). Briefly, 
TA3 cells (an I-Ad/"/I-Ed&bearing B cell-B lymphoma hybridoma) were mutagenized and 
the mutant APC lines were isolated by cycles of negative and positive immunoselection. 
Culture Conditions and IL-2 Assays.  Varying numbers (0.1-3 x  104) of the APC, either 
the wild-type TA3 or a mutant I-A  k line, were cocultured with 105 T cell bybridoma cells 
in  the  continued presence of antigen  for 24  h  (18).  The  medium  used  in  all  of the 
experiments consisted of RPMI  1640 supplemented with 8% fetal calf serum, 3 mM L- 
glutamine,  5  X  10  -~  M  2-mercaptoethanol, penicillin, and  Hepes. The level of T  cell 
stimulation was determined by quantitating the amount of IL-2 present in the supernatant. 
HT-2 cells  (4  ×  103) were cultured for 36 h  in  the presence of 40%  primary culture 
supernatants, and the degree of T  cell stimulation was measured by the incorporation of 
[~H]thymidine into  DNA.  We  could quantitate  the  level of IL-2  by assaying a  single 
concentration of primary culture supernatant, since we tested various numbers of APC 
for each  group and  used  the  maximal  values  that  were on  the  linear portion of the 
standard curve. The values represent the mean counts per  minute (cpm) of triplicate 
culture wells. The standard deviations never exceeded 20% of the mean. 
HEL Peptides.  The preparation and purification of the tryptic peptides of HEL have 
been previously described (20). For the HEL(46-61) tryptic fragment both the purified 
fragment and a corresponding synthetic peptide were used with  identical results.  The 
tryptic peptide HEL(34-45) was identified by determining the amino acid composition of 
the single high performance liquid chromatography (HPLC)-purified peak that stimulated 
the C11 .A2, A6.A2, and 18N.30 T  hybrids. The amino acid composition of this peak fit 
exactly with that predicted for the tryptic fragment HEL(34-45). The amino acid sequence 
of HEL(34-45) is Phe-Glu-Ser-Asn-Phe-Asn-Thr-Glu-Ala-Thr-Asn-Arg and the sequence 
for HEL(46-61) is Asn-Thr-Asp-Gly-Ser-Thr-Asp-Tyr-Gly-Ile-Leu-Glu-Ile-Asn-Ser-Arg. 
Monoclonal  Antibodies (mAb).  These have been described and referenced in previous 
reports (8,  9,  15,  19). The majority of the A~- and A~-specific mAb were produced by 
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Results 
Class H I-A k Mutant Cell Lines.  The production and characterization  of some 
of the A~ mutant cell lines has been described previously (8, 9,  15,  19). A more 
detailed  characterization  of the remainder  of the  A~ mutant  cell lines and  the 
A~ variant  cell lines will  be presented  elsewhere (L.  Glimcher,  D.  McKean,  in 
preparation).  All of these lines were produced from the parent  line, TA3, a  B 
cell-B lymphoma  hybridoma  produced from the  fusion  of (BALB/c ×  A/J)F1 
spleen cells with the  M12.4.1  BALB/c Iad-bearing  B lymphoma (18).  This was 
accomplished by cycles of negative and positive immunoselection with different 
mAb specific for A~ or A k.  By varying the mAb selected for the negative and 
positive  immunoselection  steps,  a  panel  of  cell  lines  with  distinct  serologic 
phenotypes was obtained. The phenotypes of the six A~ variant cell lines and the 
three A~ variant cell lines, as defined by their reactivity to a  large panel of A~- 
and A~-specific mAb, is shown in Tables I and  II.  Note that  cell line 89 reacts 
with  none  of the anti-I-A k mAb and  thus expresses no  I°A  k molecule.  It does 
express an  I-E  k molecule (not shown) (9).  The  remainder  of the cell  lines  lost 
reactivity with certain mAb but retained reactivity with others. Although several 
of the cell lines appear serologically similar (A 19 and  LD3; 3J9 and JE50) they 
have clear-cut functional differences, as shown below. These APC lines all (except 
89)  constitutively  express  I-A  k,  I-E  k,  I-A  ~,  and  LE  d molecules  at  comparable 
levels to the wild-type TA3 cell line. 
Reactivity  with Class H Mutant APC Divides  the HEL Hybridomas  into Multiple 
Groups.  The panel of HEL-specific hybridomas arose from four separate fusions 
of primed lymph node cells from CBA/J mice (hybrids 2A11,  3A9,  19.47, and 
TABLE  ] 
Phenotypes of the Ak~ Variant Cell Lines 
Anti-A~ mAb 
10.2.16  40A  40N  39B  39E  40L  40F  40M 
TA3(wild-type)  ++  ++  ++  ++  ++  ++  ++  ++ 
A19  +/-  -  -  +/-  -  ++  ++  - 
JT1  -  ++  ++  ++  ++  ++  ++  ++ 
40LB3  ++  ++  ++  ++  ++  -  -  NT 
K5  ++  -  -  +/-  -  ++  ++  ++ 
LD3  +/-  -  -  +/-  -  ++  ++  - 
89  ........ 
++,  Wild-type; +/-, weak positive signal, occasionally negative; -,  negative; NT,  not tested. 
TABLE  II 
Phenotypes of the A~ Variant Cell Lines 
Anti-A~ mAb 
39J  39c  40J  H116.32  1E9  2All 




++  ++  ++  ++  ++ 
_  _  _  ++  ++ 
_  _  _  ++  ++ 
_  _  _  ++  ++ 
++,  Wild-type; -,  negative. ALLEN  ET  AL.  1267 
18N.30) or from B10.A mice (A2.2B2, C10, C4.A1, C4.A2, A4.A1, A6.A2, and 
B 14) with the AKR thymoma BW5147. The basic experimental  protocol involv- 
ing  coculturing  these  hybridomas  with  the  class  II  mutant  APC  lines  in  the 
presence of native  HEL and testing the supernatant  for IL-2 activity 24 h  later. 
The  results  of a  typical experiment  testing the ability of the panel of A~ mutant 
cell  lines  to  present  native  HEL  to  the  10  HEL-specific  I-Ak-restricted  T  cell 
hybridomas is shown in Table  III. The  wild-type TA3  cells were able to present 
HEL  to all  of the  10  I-Ak-restricted  cell  lines  in  addition  to  an  I-Ek-restricted 
HEL-specific hybridoma, B14.  The  89 cell line, as expected, stimulated only the 
I-Ek-restricted  B14  cell  line,  confirming  that  the  other  10  cell  lines  are  I-A  k 
specific.  Two of the A~ mutant  lines, JT1  and 40LB3, presented  HEL to all the 
hybridomas  equally as  well  as the  TA3  cell.  Thus,  in  these  lines,  there  was  no 
discernible  functional effect of the altered  A~ molecules on APC ability.  On the 
other  hand,  the  K5  mutant  cell  could  stimulate  none  of  the  I-Ak-restricted 
hybrids: this was not due to a  generalized  loss of APC function, since it activated 
the  B14,  I-Ek-restricted  hybrid  perfectly  well.  The  results  obtained  from  an 
analysis  of these  10  hybridomas  with  the  remaining  two  A~  mutant  cell  lines, 
A19 and  LD3,  however,  subdivided  the  T  hybridomas into three  groups.  The 
group  I  hybrids  were  not activated  by the  A19  cell  line  but  were  activated  by 
the  LD3  cell  line,  in a  manner  ranging from modest activation  (19.47)  to wild- 
TABLE  III 
A~ Variant APC Lines Divide the T Hybridomas  into Several  Groups 
HEL-spe- 





I  C10  117,183  695  425  105,600  108,690  1,218  123,858 
C4.A1  24,839  571  265  21,118  107,989  395  16,599 
67,444  713  288  43,740  65,332  616  20,151 
CI 1.A2  169,701  4,918  1,353  74,912  161,853  6,917  169,268 
2A11  101,583  1,126  939  29,320  92,551  1,049  111,223 
A4.AI  71,966  829  638  27,115  68,037  486  55,738 
19.47  116,634  584  520  14,532  111,206  947  108,750 
3A9  46,164  441  82,336  572  145,468  406  42,254 
A2.2B2  118,238  385  81,941  85,026  91,484  649  135,912 
18N.30  23,352  262  5,861  7,632  56,160  375  21,487 
A6.A2  137,081  585  14,078  74,036  123,870  408  115,98 
IV  B14  103,538  115,304  64,280  103,712  129,337  123,278  138,239 
T  hybridoma cells (10 s) were cocultured with the designated  stimulator cells in 0.2 ml of complete 
medium  in  the presence  of native  HEL (100  ~g/ml).  After 24  h  of culture,  supernatants  were 
collected  and assayed for IL-2 content in a secondary culture of HT-2 cells. HT-2 cells (4 x  l0  s) 
were cultured  for 36  h  in  the presence of 40%  primary culture supernatant,  and the degree of 
stimulation  was measured by the incorporation of [SH]thymidine into DNA.  Varying numbers of 
stimulators  of each type, from 1 to 30 x  103, were used. Only the maximum response  obtained is 
shown. These were generally achieved with  1-10 x  10  s stimulators  per well. Positive responses are 
underlined. Responses were determined to be positive if they were twice the magnitude of the cpm 
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type (C10,  C4.A1). The group II hybrid, 3A9, had a  reciprocal pattern to the 
group I  hybrids, since the A19 but not the LD3  cell could present antigen to 
this hybridoma. The group III hybrids showed yet another phenotype of acti- 
vation, since both the A19 and LD3 cell lines could present HEL to these three 
hybrids. Thus, as probed with this panel of A~ variant APC  lines, these HEL- 
specific T cells appear to recognize several distinct epitopes on the I-A  k molecule. 
To further define determinants on the I-A  k molecule responsible for antigen 
presentation we examined the contribution of the A~ molecule to the formation 
of the restriction site used by each hybridoma. Table IV shows the results of a 
representative experiment testing  the ability of the three A~ mutant  lines  to 
activate the panel of hybridomas. The 3J9 and JE67 lines are serologicaily and 
functionally identical  while  the JE50  cell  line,  although  serologically similar, 
displayed very disparate functional properties. Specifically, the 3J9 and JE67 cell 
lines activated all the hybridomas except the two group I hybridomas, C 10 and 
C4.A1, while the JE50 cell line activated only the group I hybridomas C10 and 
19.47. 
When the results of the ability of the I-A~ and I-A~ mutant cell lines to present 
antigen are combined, the panel of T  cell hybridomas can be divided into six 
separate groups (Table VI). Groups Ia and Ib contain the T  cells C10 and C4.A1, 
respectively. These two groups are distinguished from the other four by their 
failure to react to theJE67 and 3J9 A~ mutant APC lines. They are distinguished 
from each other by their differential reactivity with the JE50 cell. Groups Ic and 
Id contain four T  cells,  C11,A2,  2A11,  A4.A1,  and  19.47,  all  of which have 
identical reactivity patterns to the I-A~ mutants. Two findings differentiate group 
Ic and Id from I~ and Ib hybrids: (a) the ability of  JE67 and 3J9 to present HEL 
TABLE  IV 
A~ Variant APC Lines Further Subdivide the T Hybridomas 
Group  HEL-specific T  Experiment 1  Experiment 2 
hybridoma  TA3  JE67  JE50  TA3  3J9.2 
cpm  cpm 
la  C10  59,201  1,360  18,579  ll2,010  787 
Ib  C4.A 1  47,286  619  943  83,305  3,957 
Ic  CI 1.A2  65,730  118,770  575  101,561  98,187 
2A11  33,665  48,379  365  101,583  92,984 
A4.A1  45,102  107,751  531  49,873  108,880 
Id  19.47  69,393  34,214  11,602  177,734  94,499 
II  3A9  43,629  68,932  502  63,107  98,217 
Ill  A2.2B2  30,096  22,264  231  45,266  50,049 
18N.30  41,913  34,392  249  53,290  51,549 
A6.A2  49,190  48,742  262  113,565  106,628 
IV  B14  61,970  52,506  67,585  109,671  107,730 
Assay performed as detailed in the legend to Table III. ALLEN ET  AL.  1269 
to the former, and (b)  the diminished ability of LD3 to stimulate the group  I~ 
and Ia T  cells. Groups Ic and Ia are distinct since the JE50 cell can activate the 
19.47 hybridoma but not the other hybrids. Group II consists of only one T  cell 
hybrid, 3A9, whose unique response pattern is its activation by the A19 cell but 
not by the LD3 cell. Three T  cell hybrids belong to group III, A2.2B2,  18N30, 
and A6.A2. Their distinguishing response pattern is that both the A19 and LD3 
mutant cells can present HEL to them. Group IV contains the I-E-restricted T 
cell hybrid. This data is summarized schematically in Table VI. 
HEL  Hybrids  Recognize at Least  Three Distinct Determinants  on  the HEL Mole- 
cule.  The second portion of this analysis involved determining the fine antigen 
specificity of the  11  HEL-specific T  cell hybridomas. Two of the hybrids, 2A11 
and 3A9,  have already been extensively characterized and found to respond to 
the tryptic fragment of HEL containing residues 46-61  (20). It was subsequently 
shown (22)  that the  minimal stimulatory peptide  for both  2A11  and  3A9  was 
HEL(52-61): furthermore, the immunogenicity of this peptide has been localized 
to the Leu 56 residue. 
We initially determined which if any of the other nine T  cell hybrids were 
recognizing HEL(46-61).  Using wild-type TA3  cells as the presenting cells we 
determined  that  three  other  T  cell  hybridomas,  C10,  A4.A1,  and  A2.2B2 
responded to HEL(46-61). These three T  cell lines responded to both the tryptic 
fragment HEL(46-61)  and the synthesized HEL(46-61)  and  to  no other  HEL 
tryptic  fragments  (Table  V).  We  next  tested  the  ability of the  other  tryptic 
fragments of HEL  to  stimulate  the  remaining  six  hybridomas.  Three  of the 
hybridomas  responded  to  a  tryptic  fragment  containing  the  residues  34-45 
(Table V). The C 1 1.A2 and the A6.A2 cells responded strongly to HEL(34-45), 
while  the  18.N30  cells'  response  was  much  weaker.  These  three  T  cell  lines 
responded only to this HEL(34-45) tryptic fragment; thus, we have identified a 
second  determinant(s)  on  the  HEL molecule that  three  of the T  cell  hybrids 
recognize. It is interesting that, for the two determinants on the HEL molecule 
TABLE V 
Fine Antigen Spec~city of riLL Hybridomas 
HEL-specific T  HEL  46-61  34-45 
hybridoma 
cpm 
C10  128,927  79,353  415 
C4.A1  102,097  246  570 
C11.A2  13,328  226  128,504 
A4.A1  7,701  18,073  692 
A6.A2  23,800  262  88,160 
19.47  123,783  221  740 
A2.2B2  99,350  110,050  813 
18N.30  13,801  315  34,768 
B  14  109,671  2,987  2,656 
T hybridoma cells (10 ~) were cocultured with 3 x  10  4 TA3 cells along 
with either 7 uM HEL, 10 t~M HEL(46-61), or 5 tJM HEL(34-45). The 
level of T cell stimulation was determined as described in Table Ill. The 
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TABLE  VI 
Summary of the Response Patterns  to I-A~ Mutants, l-A k Mutants, and Antigen Spec~city 
Group  (;ell  line 
Wild-  l-A~ Mutants  l-A~ Mutants  Antigen Specificity 
type 
TA3  89  A19  LD3  JTI  K5  40LB3  JE67  3J9.2  JE50  46-61  34-45  ?? 
la  CI0  ++  -  ++  ++  -  ++  -  -  ++  ++ 
lb  C4.A 1  ++  -  -  ++  ++  -  ++  -  -  -  ++ 
Ic  C 11 .A2  ++  -  -  +  ++  -  ++  ++  ++  -  ++  - 
lc  2A 11  ++  -  -  +  ++  -  ++  ++  ++  ++  - 
Ic  A4.AI  ++  -  -  +  ++  -  ++  ++  ++  ++  - 
ld  19.47  ++  -  -  +  ++  -  ++  ++  ++  +  -  ++ 
II  3A9  ++  -  ++  ++  -  ++  ++  ++  -  ++ 
III  A6.A2  ++  -  +  ++  ++  ++  ++  ++  -  -  ++ 
HI  A2.2B2  ++  -  ++  ++  ++  ++  ++  ++  -  ++  - 
Ill  18N.30  ++  -  +  +  ++  ++  ++  ++  -  -  ++ 
IV  BI4  ++  ++  ++  ++  ++  ++  ++  ++  ++  ++  -  -  - 
++,  Wild-type response; +, positive but  less than  wild-type response; -,  negative response;  ??, antigen  specificity was only localized to 
HEL(13-105). 
that  8  of the  10  I-Ak-restricted  hybrids recognize,  there are colinear but non- 
overlapping sequences. Perhaps this is because the physiological processed frag- 
ment of HEL produced by the APC is a  large fragment that contains both the 
HEL(34-45)  and  HEL(46-61)  determinants.  The  remaining  three  cell  lines, 
C4.A1,  19.47, and B14, did not respond to any of the tryptic fragments of HEL, 
including the HEL(34-45) and HEL(46-61) fragments. We therefore tested other 
proteolytic fragments of HEL for their ability to stimulate these three cell lines. 
One scheme for generating fragments was based on the assumption that trypsin 
was cleaving and thus inactivating the immunogenic determinant.  We therefore 
tried a chymotryptic digest and a trypsin digest of HEL in which the Lys residues 
were blocked by citraconylation  and only the arginyl bands were cleaved (23). 
We were still unable to identify a single peptide that could stimulate any of these 
three cell lines. Both the C4.A1  and  19.47 hybridomas did respond to the large 
CNBr fragment of HEL containing residues 13-105. Thus, for C4.A 1 and 19.47 
we can  only localize  the  immunogenic  determinant  to  the  fragment  HEL(13- 
105).  Likewise, we have not been able to identify the HEL determinant  recog- 
nized by the I-Ek-restricted B 14 cell. The B 14 cells do recognize some processed 
form of HEL since prefixed APC could not present native HEL to the B14 ceils 
(not shown), but we have been unable to identify any fragment that can stimulate 
these  cells.  Thus,  these  experiments  demonstrate  that  this  panel  of  11  It-2 k- 
restricted T  hybridomas recognize,  at a  minimum,  three distinct determinants 
on the HEL molecule. 
Discussion 
When the HEL antigen specificities recognized by the 10 I-Ak-restricted T  cell 
hybridomas are combined with their response patterns to the A~ and A~ variant 
cell lines, a very complex pattern emerges.  In fact, this analysis reveals that the 
10 T  cell hybrids can be divided into 8 distinct groups. There does not appear 
to be any correlation  between the  peptide  recognized  by the  hybridomas and 
their response pattern to the panel of I-A variant APC lines. Thus, T  cells that 
recognize the peptide 46-61  belong to the groups  Ia,  Ic,  II,  and  III.  Similarly, 
those recognizing  peptide 34-45  belong to groups Ic and  III.  Of the  10 T  cell ALLEN  ET  AL.  1271 
hybrids there are only two pairs that have the same reactivity pattern and antigen 
specificity:  2A11-A4.A1  and  A6-A2-18N.30.  The  major  conclusion  from  this 
analysis, therefore,  is that  many different determinants  or TcR ligands can  be 
generated from a single Ia molecule and a simple globular protein. Furthermore, 
in  agreement  with  previous work (8,  19),  it  appears  that  both  the  A~ and  A~ 
molecules are necessary to form the restriction  element  used, since the K5 A~ 
mutant cell line stimulated none of the T  cells, while none of the T  cells could 
be activated by all three A~ mutant cell lines. That the A s and A~ molecules used 
must  be homozygous is  supported by the  recent  finding  that  very few hybrid 
molecules are present in these cells (24). 
The T  cell hybrids used in this study were generated from two different mouse 
strains,  CBA/J and B10.A.  From our analysis we found no correlation between 
the strain of origin of the hybrid and their reactivity pattern to the mutant I-A  k 
APC or their antigen specificity. In fact, the two pairs of T  cell hybrids that we 
could not distinguish  from each other,  2A11-A4.A1  and  A6.A2-18N.30,  were 
each  composed of T  hybrids from two different  mouse strains.  These experi- 
ments, therefore,  identify an immunodominant  determinant on the HEL mole- 
cule recognized by mice of the H-2 k haplotype. Clearly, the HEL(46-61) peptide 
contains the major determinant  since 5  of the  10 T  cell hybrids responded to 
this  fragment.  Three  of the  T  cell  hybrids  recognized  a  second  determinant 
located in the HEL(34-45) peptide. These two determinants appear to represent 
a reasonable portion of the T  cell response in H-2  k mice, since 8 of the 10 hybrids 
responded to one or the other of them. We were unable to identify a proteolytic 
fragment of HEL other than the large CNBr fragment HEL(13-105), which the 
C4.A1 and the 19.47 cells recognize. Shastri et al. (25) have shown that a minor 
determinant  recognized  by H-2  k mice is  located in  the  HEL(74-96)  fragment. 
This fragment did not stimulate either C4.A1  or  19.47; however, the HEL(74- 
96) peptide could potentially contain part of an immunogenic determinant  that 
was destroyed by the cleavage of HEL by trypsin to produce the fragment. 
Obviously, this analysis is only as complete as is the definition of distinct regions 
on the I-A  k molecule, as well as the fine specificity ofpeptide recognition. Further 
efforts in  these directions  may result  in an even  more complex picture than  is 
presented  here.  Nevertheless,  this  already  striking  heterogeneity  must  be  re- 
flected at  the  level  of TcR  proteins.  In  this  regard  it  is  interesting  that  the 
cloning and sequencing of TcR 3 chain genes from seven members of a BALB/ 
c  thymocyte  library  revealed  remarkably  little  heterogeneity  in  the  V0 genes 
used (26). It will be interesting to isolate and sequence both TcR beta and alpha 
chain genes from selected members of this panel of HEL-specific T  hybridomas 
to determine whether a correlation exists between the Ia determinant or peptide 
recognized and the variable, diversity, or joining (V, D, or J) TcR 3 and a  gene 
segments used. 
The two T  cell hybridomas whose fine specificity has been most extensively 
studied  are  the  2A11  and  the  3A9  cell  lines  (21,  22).  It  has been shown that 
these two hybrids recognize very similar but distinct determinants  composed of 
the  same  essential  residues,  52-61  (22).  In  this  study  we  have  found  a  clear 
difference between these two T  cell lines in their response patterns to the panel 
of mutant APC lines. The A19 cell line failed to present HEL to the 2A11  cells 1272  MULTIPLE  DETERMINANTS  FORMED  BY  I-A  k  MOLECULE  AND  LYSOZYME 
but did present to the 3A9 cells. Conversely, the LD3 cell line could present to 
the 2A11 cells, but not to the 3A9 cells. The site of the mutation of the A19 cell 
line  has  recently  been  determined  to  be  a  single  base  change  resulting  in  a 
glutamine to a lysine substitution at position 67 in the I-A~ chain (M. Brown, L. 
Glimcher,  E.  Nielsen,  W.  E.  Paul, and  R. Germain,  submitted for publication). 
The  location  of the  mutation  in  the  LD3  I-A~ chain  is currently  being deter- 
mined. 
Putting all of the patterns for the 2A11 and 3A9 T  cells together allows us to 
analyze how the ligand  recognized by these two TcR may be formed.  Clearly, 
the  same  HEL peptide  46-61  can  combine with  I-A  k to  differentially activate 
these  two  T  cells.  It appears  that  position  67  of the  A~ chain  is  an  essential 
residue in the formation  of the determinant  recognized by the 2A11  cells, but 
that  it is  not involved in  the  formation  of the  determinant  recognized  by the 
3A9 cells. Conversely, the mutational  site in  the  LD3  I-A~ chain  is essential in 
the  formation  of the determinant  recognized  by the  3A9  cells but not by the 
2A11  cells.  Whether  this  is  because  these  particular  regions  of the  class  II 
molecule interact  with the HEL peptide 46-61, or whether it is the interaction 
between TcR proteins and these residues that determines the T  cell specificity, 
cannot be determined  from these data.  In other words, the 52-61  peptide may 
use different  residues  of the  A~ chain  to  interact  with,  thus  creating  distinct 
determinants, or, alternatively, the peptide's interaction with A~ may be invariant 
and  the differential  reactivity of the  2A11  and  3A9 hybrids determined  solely 
by the TcR-I-A~ interaction.  We think it is unlikely that the failure of the A19 
or LD3 cells to activate certain T  cells is secondary to an absolute inability of the 
peptide to associate productively with these mutant molecules, since the mutant 
cell lines can activate other T  cells that also recognize this peptide. However, it 
is possible that the active peptide recognized by these T  cells is, in fact, slightly 
different.  The  answer  to  some  of these  questions  will  require  direct-binding 
studies of purified  mutant  Ia  antigens  to  the  relevant  peptides  as  well  as  the 
crystallographic  structure  of the wild-type and  mutant  molecules.  Since recent 
studies (27) have established  that  direct binding  of the  HEL peptide 46-61  to 
purified Ia antigens from the wild-type APC line, TA3, does occur, it should be 
possible to perform these same assays with purified mutant molecules. 
SuIYH~ary 
We have examined  the  individual  contributions  of the  I-A~ chain,  the  I-A~ 
chain,  and the foreign antigen  hen egg-white lysozyme (HEL) in the formation 
of the determinant being recognized by the T  cell receptor. As functional probes 
we have used (a) a  panel of I0  HEL-specific T  cell hybridomas,  (b) a  panel  of 
antigen-presenting  cells (APC) possessing  mutations  in  either  the  I-A~ or  I-A~ 
chains, and (c) proteolytic fragment of HEL and related synthetic peptides. The 
ability of the I-A~ and I-A~ mutant cell lines to present antigen to the  10 T  cell 
hybridomas divided these T  cells into six distinct groups. These HEL-specific T 
cells therefore appear to recognize several distinct domains on the I-A  k molecule. 
The  10  T  cell  hybrids  were  then  shown  to  recognize  at  least  three  distinct 
determinants on the HEL molecule, with 8 of the 10 hybrids recognizing one of 
two major determinants  HEL(46-61) or HEL(34-45).  Combining the response ALLEN  ET  AL.  1273 
patterns  to  the  panel  of I-A  k  mutant  APC  lines  with  the  antigen  specificity 
revealed that the 10 T  cell hybrids recognized at least eight unique determinants 
formed by the I-A~ chains, I-A~ chains, and HEL peptides. This analysis provides 
direct evidence that a large number of different determinants or T  cell receptor 
ligands can be generated from a single Ia molecule and a simple globular protein. 
We thank Robert Evans for technical assistance, Mary Littlefield for preparation of the 
manuscript, and Gary Matsueda for the amino acid analyses. 
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